Angeliq Tablet, Film Coated
Product Images NDC 50419-482

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Angeliq (NDC 50419-482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical structure diagrams of the active ingredients drospirenone and estradiol as labeled in the image. The structures depict key molecular features of each hormone.*

FDA Label Image

Figuree 1 (Image 02)

Two line graphs showing mean serum concentrations of drospirenone and estradiol over 24 hours. The top graph is for 0.25 mg drospirenone/0.5 mg estradiol, and the bottom graph for 0.5 mg drospirenone/1 mg estradiol. Both graphs plot concentration (ng/mL for drospirenone, pg/mL for estradiol) against time in hours.*

FDA Label Image

Figure 2 (Image 03)

A line graph showing the proportion of subjects (%) experiencing a specific effect over 12 time points, comparing two dosages of drospirenone and estradiol tablets (0.25 mg/0.5 mg and 0.5 mg/1.0 mg). The graph includes data series labeled with report numbers A49095 and A02827, plotted with square and circle markers respectively, illustrating trends in subject responses across the study period.*

FDA Label Image

Angeliq 1's Trade (Image 04)

Angeliq tablets packaging label showing drospirenone and estradiol 0.5 mg/1 mg strength. The label states the film-coated oral tablet dosage form and includes Bayer HealthCare Pharmaceuticals Inc. branding. The package indicates a 28-tablet supply with dosage information visible on multiple panels.*

FDA Label Image

Angeliq 0.25/0.5 mg Carton (Image 05)

Packaging label for Angeliq tablets containing drospirenone and estradiol at a strength of 0.25 mg/0.5 mg. The label includes dosage form information as film-coated tablets, oral route, and lists Bayer HealthCare Pharmaceuticals Inc. as the labeler. The box is designed for 28 tablets and features purple and yellow coloring with the Bayer logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.